ClinicalTrials.gov record
Not yet recruiting Phase 3 Interventional

A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

ClinicalTrials.gov ID: NCT07497087

Public ClinicalTrials.gov record NCT07497087. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 12:17 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind, Randomised, Placebo-controlled Trial Evaluating the Efficacy and Safety of Oral Nerandomilast Treatment in Patients With Systemic Sclerosis (SSc)

Study identification

NCT ID
NCT07497087
Recruitment status
Not yet recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Boehringer Ingelheim
Industry
Enrollment
448 participants

Conditions and interventions

Interventions

  • Nerandomilast formulation 1 Drug
  • Nerandomilast formulation 2 Drug
  • Placebo matching nerandomilast formulation 1 Drug
  • Placebo matching nerandomilast formulation 2 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 8, 2026
Primary completion
Feb 25, 2030
Completion
Mar 16, 2030
Last update posted
Apr 28, 2026

2026 – 2030

United States locations

U.S. sites
30
U.S. states
17
U.S. cities
26
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294
Banner - University Medicine Rheumatology Clinic Phoenix Arizona 85006
Arizona Arthritis and Rheumatology Associates - Paradise Valley Scottsdale Arizona 85032
University of California Los Angeles Los Angeles California 90095
Paradigm Clinical Research - San Diego San Diego California 92108
Stanford University School of Medicine Stanford California 94305
Amicus Arthritis and Osteoporosis Center Whittier California 90602
University of Colorado Denver Aurora Colorado 80045
Georgetown University Washington D.C. District of Columbia 20007
Millennium Research - Ormond Beach Ormond Beach Florida 32174
Integral Rheumatology and Immunology Specialist Plantation Florida 33324
BioResearch Partner - South Miami South Miami Florida 33143
Northwestern University Chicago Illinois 60611
The University of Chicago Medical Center Chicago Illinois 60637
DelRicht Research-New Orleans-64100 New Orleans Louisiana 70115
Johns Hopkins Hospital Baltimore Maryland 21224
Massachusetts General Hospital Boston Massachusetts 02114
University of Michigan Ann Arbor Michigan 48109
Clinical Research Institute of Michigan, LLC - St. Clair Shores Saint Clair Shores Michigan 48081
M Health Fairview University of Minnesota Medical Center Minneapolis Minnesota 55455
Rutgers Robert Wood Johnson Medical School New Brunswick New Jersey 08901
Hospital for Special Surgery New York New York 10021
Icahn School of Medicine at Mount Sinai New York New York 10029
Columbia University Medical Center-New York Presbyterian Hospital New York New York 10032
University of Pennsylvania Philadelphia Pennsylvania 19104
Thomas Jefferson University Philadelphia Pennsylvania 19107
West Tennessee Research Institute Jackson Tennessee 38305
Arthritis & Rheumatology Institute - Allen Allen Texas 75013
Tekton Research, Inc - West Gate Boulevard Austin Texas 78745
The University of Texas Health Science Center at Houston Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 200 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07497087, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 28, 2026 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07497087 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →